Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Leveraging a self-cleaving peptide for tailored control in ...

Skip to main content Skip to article View PDF Under a Creative Commons license Open access Highlights • We present a strategy to expand BioID-only controls in proximity labeling experiments • We introduce self-cleaving and mutant T2A linkers for differential p

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Skip to main contentSkip to article

Under a Creative Commons license

Open access

Highlights

  • We present a strategy to expand BioID-only controls in proximity labeling experiments

  • We introduce self-cleaving and mutant T2A linkers for differential proximity labeling

  • MUTT2A/T2A differential analysis efficiently filters common BioID contaminants

  • We present a rapid and customizable plasmid assembly platform for proximity labeling

Motivation

In proximity labeling proteomics, protein-protein interactions are identified by in vivo biotinylation. However, the current lack of a universally applicable negative control for differential analysis affects accurate mapping of the interactome. To bridge this gap, we conceptualized a system based on the T2A self-cleaving peptide to match expression levels between control and bait protein setups while using the same bait protein. In addition, we implemented a versatile modular cloning system to build mammalian expression vectors for, but not limited to, proximity labeling assays.

Summary

Protein-protein interactions play an important biological role in every aspect of cellular homeostasis and functioning. Proximity labeling mass spectrometry-based proteomics overcomes challenges typically associated with other methods and has quickly become the current state of the art in the field. Nevertheless, tight control of proximity-labeling enzymatic activity and expression levels is crucial to accurately identify protein interactors. Here, we leverage a T2A self-cleaving peptide and a non-cleaving mutant to accommodate the protein of interest in the experimental and control TurboID setup. To allow easy and streamlined plasmid assembly, we built a Golden Gate modular cloning system to generate plasmids for transient expression and stable integration. To highlight our T2A Split/link design, we applied it to identify protein interactions of the glucocorticoid receptor and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid and non-structural protein 7 (NSP7) proteins by TurboID proximity labeling. Our results demonstrate that our T2A split/link provides an opportune control that builds upon previously established control requirements in the field.

Keyword(s)

proximity labeling

T2A peptide

glucocorticoid receptor

nucleocapsid protein

non-structural protein 7

Golden Gate assembly

TurboID

proteomics

interactomics

T2A split/link

Research topic(s)

CP: Biotechnology

© 2024 The Authors. Published by Elsevier Inc.

P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →